| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,360 |
11,383 |
$759K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,513 |
4,503 |
$349K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,737 |
3,157 |
$245K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,969 |
4,205 |
$104K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,085 |
5,054 |
$82K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,105 |
1,781 |
$75K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,786 |
4,224 |
$69K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,364 |
1,537 |
$53K |
| 87428 |
|
260 |
228 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
119 |
97 |
$5K |
| 87807 |
|
48 |
39 |
$426.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
15 |
$151.42 |
| 81003 |
|
43 |
38 |
$66.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
39 |
27 |
$28.39 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
50 |
30 |
$0.00 |
| 3078F |
|
2,075 |
1,752 |
$0.00 |
| 3074F |
|
2,000 |
1,714 |
$0.00 |
| 3008F |
|
2,860 |
2,449 |
$0.00 |
| 1036F |
|
1,197 |
998 |
$0.00 |
| 3079F |
|
64 |
53 |
$0.00 |
| 3075F |
|
12 |
12 |
$0.00 |
| MCAID |
|
29 |
26 |
$0.00 |
| 1034F |
|
13 |
12 |
$0.00 |